External validation of a prognostic model for overall survival (OS) in men with metastatic castration-resistant prostate cancer (mCRPC).

Authors

• William Kelly

Publication/Presentation Date

5-2019

Volume

37

Issue

15

Published In/Presented At

DOI: 10.1200/JCO.2019.37.15_suppl.5022

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article